BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27

• BioMidwest

  Baxter International, Inc. To Present At Barclay’s Global Healthcare Conference

  February 20, 2015

   · 

  1 min read
• Teva Pharmaceutical Industries To Present New Respiratory Data At 2015 Annual Meeting Of The American Academy Of Allergy, Asthma And Immunology

  February 20, 2015

   · 

  1 min read
• Genetown

  Voyager Therapeutics To Present At Cowen and Company 35th Annual Health Care Conference

  February 20, 2015

   · 

  1 min read
• Business

  Aerocrine Achieves Record Sales For The 4th Quarter And Full Year

  February 20, 2015

   · 

  1 min read
• Policy

  Pfizer Release: FDA Accepts Supplemental New Drug Application For Priority Review Of RAPAMUNE® (Sirolimus) For Treatment Of Lymphangioleiomyomatosis (LAM)

  February 20, 2015

   · 

  8 min read
• BioCapital

  Immunomic Therapeutics To Present Data On Its Proprietary LAMP Vaccine Platform At 2015 American Academy of Allergy, Asthma and Immunology (AAAAI) Meeting

  February 20, 2015

   · 

  3 min read
• Drug Development

  Cerecor Inc. Bolsters Clinical Pipeline With Acquisition Of Phase 2-Ready Kappa Opioid Receptor Antagonist From Eli Lilly

  February 20, 2015

   · 

  2 min read
• Ferring Pharmaceuticals Announces European Launch Of CORTIMENT MMX (Budesonide) For Ulcerative Colitis, And New Data Re-Confirms Safety And Efficacy

  February 20, 2015

   · 

  6 min read
• Business

  Sterigenics International, Inc. And Nordion Announce Landmark Canada-U.S. Partnership Agreement To Provide A Long-Term, Reliable Supply Of Medical Isotopes

  February 20, 2015

   · 

  5 min read
• FDA

  Celgene Release: REVLIMID (Lenalidomide) Approved By The European Commission For The Treatment Of Adult Patients With Previously Untreated Multiple Myeloma Who Are Not Eligible For Transplant

  February 20, 2015

   · 

  13 min read